Recent evidence suggests that HYOU1 is upregulated in a series of tumours, such as breast tumours, nasopharyngeal carcinoma, epithelial ovarian cancer and Kaposi's sarcoma.9, 10, 11, 12. This evidence concerns the gene HYOU1 and neoplasm.